相关实验视频

Updated: Jul 2, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

STING激活剂2'3'-cGAMP增强的基于HSV-1的菌性病毒疗法

Patricia Angela Sibal^1,2, Shigeru Matsumura¹, Toru Ichinose¹

¹Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Japan.

Molecular oncology

|February 24, 2024

概括

将瘤病毒 (OV) 与STING激动剂结合起来可以增强抗瘤免疫力. 这种疗法可以促进T细胞的增殖和免疫记忆,即使在未经治疗的瘤中,通过克服瘤细胞STING-干扰素通路中的缺陷.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
癌症治疗癌症治疗

背景情况:

瘤病毒 (OVs) 通过选择性向瘤细胞并增强抗瘤免疫力,对癌症治疗具有前途.
干扰素基因刺激剂 (STING) -干扰素 (IFN) 途径激动剂激活树突细胞 (DCs) 以获得抗瘤益处.
激活STING-IFN通路以抑制OV复制的潜力限制了联合疗法的探索.

研究的目的:

研究一种基于HSV-1的OV (C-REV) 和一种膜透性STING激动剂 (2'3'-cGAMP) 对瘤的联合疗效.
评估这种联合治疗对瘤微环境和全身抗瘤免疫反应的影响.

主要方法:

使用基于结核病毒 (C-REV) 的HSV-1和一个STING激动剂 (2'3'-cGAMP).
评估了STING-IFN通路在瘤细胞中的功能.
在瘤部位和淋巴结中评估免疫细胞群 (CD8+ T细胞,DCs).
测量了全身抗瘤免疫和免疫记忆反应.

主要成果:

瘤细胞表现出缺陷的STING-IFN通路,限制了抗病毒IFN诱导.
组合疗法增加了KLRG1高PD1低CD8+T细胞的增殖,并在瘤内激活了CD103+DCs.
在组合治疗后,在淋巴结中观察到瘤特异性CD44+ CD8+ T细胞的升高.
C-REV和2'3'-cGAMP组合诱导了强大的抗瘤免疫记忆和增强的全身免疫力.

结论:

结合C-REV和2'3'-cGAMP有效地克服了瘤细胞STING-IFN通路中的缺陷.
这种组合疗法显著增强了全身抗瘤免疫力,并建立了免疫记忆.
这些发现支持将瘤病毒与STING激动剂结合起来作为一种强大的癌症免疫疗法策略的潜力.

关键词:

2′3′-cGAMPP的 2′3′-cGAMP 的 2′3′-cGAMP 的 2′3′-cGAMP 的这就是HSV1的原因.刺痛是一种刺痛.科性病毒病毒.胰腺癌是一种癌症.

更多相关视频

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation

Published on: April 2, 2012

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...